Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1Phase EARLY_PHASE1 1

Status

Completed 11Terminated 4Active not recruiting 2Withdrawn 1Unknown 1Recruiting 1

Sponsor Class

OTHER 4INDUSTRY 2INDIV 1

Study Type

Interventional 4

Sponsor

Cancer Type

Breast 2Tumor-Agnostic 1

Conditions

Breast Neoplasms 2Triple Negative Breast Neoplasms 1Neoplasms 1Leiomyoma 1Carcinoma, Intraductal, Noninfiltrating 1

Interventions

Cyclophosphamide 241Radiotherapy 217Gemcitabine 187Cisplatin 185Carboplatin 182Docetaxel 166Bevacizumab 166Paclitaxel 144Capecitabine 142Rituximab 141pembrolizumab 140Nivolumab 126Oxaliplatin 124Dexamethasone 122Fluorouracil 113fludarabine 104Radiosurgery 101Doxorubicin 99fludarabine phosphate 97Irinotecan 96Etoposide 95Lenalidomide 93Cytarabine 92Magnetic Resonance Spectroscopy 90Radiation 89Filgrastim 89Leucovorin 88Bortezomib 86Cetuximab 80Pemetrexed 79

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Terminated × OTHER × Mifepristone × Clear all
NCT03225547 2025-12-23

Study of Pembrolizumab and Mifepristone in Patients With Advanced HER2-negative Breast Cancer

University of Chicago

Phase 2 Terminated
24 enrolled
Breast

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT01138553 2019-07-08

Preoperative Testing of the Anti-Progesterone Mifepristone in Early Stage Breast Cancer

University of California, San Diego

Phase EARLY_PHASE1 Terminated
4 enrolled
Breast

Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating

NCT00832871 2018-06-29

Compassionate Use of Mifepristone in Brain/Nervous System and Other Cancers

New Mexico Cancer Research Alliance

Phase NA Terminated
4 enrolled 4 charts
Tumor-Agnostic

Neoplasms

NCT00219778 2016-04-06

A Study on the Efficacy of 10 mg Oral Mifepristone for the Treatment of Symptomatic Uterine Leiomyomas

Poitiers University Hospital

Phase 2 Terminated
20 enrolled

Leiomyoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡